Cite
HARVARD Citation
Cohen, S. et al. (n.d.). A phase I pharmacokinetics trial comparing PF‐05280586 (a potential biosimilar) and rituximab in patients with active rheumatoid arthritis. British journal of clinical pharmacology. pp. 129-138. [Online].